Drugs / Fumaric acid
last change Jun 2016 re-read 3 minutes ago

Fumaric acid

Small molecule

Developed for
psoriasis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT02474082 Comparator Apr 2015 → Jun 2016 psoriasis Novartis Pharmaceuticals Completed Met primary

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Fumaric acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474082 ↗
Known as 2-butenedioic acid, (e)- ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as Allomaleic-acid ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as Boletic-acid ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as E-297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as FEMA NO. 2488 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as Fumaricum acidum ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as INS NO.297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as INS-297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Known as NSC-2752 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160 ↗
Modality Small molecule — CHEMBL503160 ↗